Hengxin Liu

Hengxin Liu

Auto-generated profile, based on publicly available information

Hengxin Liu

Lingang Laboratory, Shanghai, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2023 in Nature Methods
Verified
Journal Article
Closed access
PDF file
LXLianshun Xie
Lianshun Xie
HLHengxin Liu
Hengxin Liu
ZYZhiwen You
Zhiwen You
LWLuyue Wang
Luyue Wang
YLYiwen Li
Yiwen Li
YCYuejun Chen
Yuejun Chen

24 July 2026 in Nature Methods
Verified
Journal Article
Closed access
PDF file
HLHengxin Liu
Hengxin Liu
YHYanhong Hong
Yanhong Hong
YZYao Santo Zhang
Yao Santo Zhang
LXLiyuan Xi
Liyuan Xi
HYHuiying Yan
Huiying Yan
WWWu Wei
Wu Wei

21 October 2025 in Research Square
Verified
Preprint
Open access
PDF file
Yifan LiuYifan Liu
Yifan Liu
MLMengzhen Li
Mengzhen Li
SLShiyan Li
Shiyan Li
HLHengxin Liu
Hengxin Liu
XZXuanpei Zhai
Xuanpei Zhai
WWWu Wei
Wu Wei
Microbial communities are extraordinarily diverse and play crucial roles in health and disease, yet current methods lack the resolution and scalability needed to dissect their genomic and ecological complexity at the single-cell level. Here, we present CAP-seq, a high-throughput single-microbe genomics platform that combines hydrogel-based semi-permeable encapsulation with moderate microfluidics to recover thousands of single-amplified genomes (SAGs) with long reads and high completeness at moderate sequencing depth. We benchmarked CAP-seq using defined microbial communities, demonstrating strain-level resolution, accurate detection of rare taxa, and genome recovery exceeding 50% at ~10× coverage. Applying CAP-seq to pediatric Clostridioides difficile infection microbiomes, we generated a high-resolution single-cell atlas comprising tens of thousands of SAGs across hundreds of species. Host-resolved profiling of the cryptic plasmid pBI143 revealed previously hidden low-abundance host associations, four new plasmid versions, and their coexistence within individuals, indicating complex plasmid evolution in situ. Longitudinal analysis during fecal microbiota transplantation and vancomycin treatment uncovered dynamic remodeling of microbial hosts, antimicrobial resistance genes, and plasmid-microbial interactions at single-cell resolution. CAP-seq enables scalable, high-performance single-cell genomics and provides a practical, widely accessible platform for microbiome analysis, paving the way for large-scale exploration of microbial dark matter, host–microbe interactions, and plasmid-microbe dynamics across diverse ecosystems.